Claims directed to isolated DNA molecules encoding proteins that inhibit cytotoxic effects of tumor necrosis factor were properly rejected for failure to satisfy written description requirement of 35 U.S.C. § 112 because the specification provided only partial amino acid sequence and, therefore, it cannot be held that DNA molecules claimed in application have been described.